Hoornenborg, E, Prins, M, Achterbergh, RCA, et al. Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report. Lancet HIV 4 (2017), e522–e528.
Hoornenborg, E, Krakower, DS, Prins, M, Mayer, KH, Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries. AIDS 31 (2017), 2179–2191.
Grant, RM, Lama, JR, Anderson, PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 363 (2010), 2587–2599.
Krebs, SJ, Ananworanich, J, Immune activation during acute HIV infection and the impact of early antiretroviral therapy. Curr Opin HIV AIDS 11 (2016), 163–172.
Deng, K, Pertea, M, Rongvaux, A, et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature 517 (2015), 381–385.
